Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Stockwatch: Biotech results indicate sector trajectory

This article was originally published in Scrip

Executive Summary

As the full year, and last quarter 2010 earnings season starts to draw to a close, we can discern current common themes – sales and earnings misses were as a result of US healthcare reform, European cost containment measures and company restructurings, and there will be more of the same in 2011. The positive earnings surprise, that investors had hoped for has largely been absent but in its place, this week, we saw a much more fundamental sign of where profitable biotechnology companies may be headed.



Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts